Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Hydrochloride Nasal Spray for Preoperative Sedation in Children
CTR20212686Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural sedation and analgesia (PSA), sponsored by Hengrui Therapeutics. Started Nov 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20212686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212686.